Teva Pharmaceutical Industries Limited (IL:TEVA)
TASE:TEVA
Want to see IL:TEVA full AI Analyst Report?
Total Valuation
Teva has a market cap or net worth of ₪120.89B. The enterprise value is 53.97B.
Market Cap₪120.89B
Enterprise Value53.97B
Share Statistics
Teva has 1,164,638,700 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,164,638,700
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Teva’s return on equity (ROE) is 0.19 and return on invested capital (ROIC) is 14.69%.
Return on Equity (ROE)0.19
Return on Assets (ROA)0.04
Return on Invested Capital (ROIC)14.69%
Return on Capital Employed (ROCE)0.16
Revenue Per Employee504.90K
Profits Per Employee41.28K
Employee Count37,000
Asset Turnover0.46
Inventory Turnover2.85
Valuation Ratios
The current PE Ratio of Teva is 23.7. Teva’s PEG ratio is -0.13.
PE Ratio23.7
PS Ratio1.94
PB Ratio4.58
Price to Fair Value4.58
Price to FCF14.18
Price to Operating Cash Flow16.57
PEG Ratio-0.13
Income Statement
In the last 12 months, Teva had revenue of 18.68B and earned 1.53B in profits. Earnings per share was 1.23.
Revenue18.68B
Gross Profit9.63B
Operating Income4.28B
Pretax Income1.34B
Net Income1.53B
EBITDA3.42B
Earnings Per Share (EPS)1.23
Cash Flow
In the last 12 months, operating cash flow was 2.44B and capital expenditures -545.79M, giving a free cash flow of 1.89B billion.
Operating Cash Flow2.44B
Free Cash Flow1.89B
Free Cash Flow per Share1.62
Dividends & Yields
Teva pays an annual dividend of 8.5, resulting in a dividend yield of ―
Dividend Per Share8.5
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.58
52-Week Price Change69.55%
50-Day Moving Average9.93K
200-Day Moving Average8.03K
Relative Strength Index (RSI)46.59
Average Volume (3m)1.92M
Important Dates
Teva upcoming earnings date is Aug 5, 2026, Before Open (Confirmed).
Last Earnings DateApr 29, 2026
Next Earnings DateAug 5, 2026
Ex-Dividend Date―
Financial Position
Teva as a current ratio of 1.04, with Debt / Equity ratio of 205.48%
Current Ratio1.04
Quick Ratio0.80
Debt to Market Cap0.46
Net Debt to EBITDA4.04
Interest Coverage Ratio4.23
Taxes
In the past 12 months, Teva has paid -194.84M in taxes.
Income Tax-194.84M
Effective Tax Rate-0.15
Enterprise Valuation
Teva EV to EBITDA ratio is 14.64, with an EV/FCF ratio of 19.59.
EV to Sales2.68
EV to EBITDA14.64
EV to Free Cash Flow19.59
EV to Operating Cash Flow16.16
Balance Sheet
Teva has ₪3.78B in cash and marketable securities with ₪17.07B in debt, giving a net cash position of -₪13.29B billion.
Cash & Marketable Securities₪3.78B
Total Debt₪17.07B
Net Cash-₪13.29B
Net Cash Per Share-₪11.41
Tangible Book Value Per Share-₪10.37
Margins
Gross margin is 51.98%, with operating margin of 22.90%, and net profit margin of 8.18%.
Gross Margin51.98%
Operating Margin22.90%
Pretax Margin7.17%
Net Profit Margin8.18%
EBITDA Margin18.31%
EBIT Margin12.50%
Analyst Forecast
The average price target for Teva is ₪13,708.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target₪13,708.00
Price Target Upside41.73% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast-5.23%
EPS Growth Forecast―